Cargando…
Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China
OBJECTIVES: To evaluate the clinical and economic consequences of continuous subcutaneous insulin infusion (CSII) vs. multiple daily injections (MDI) in children and adolescents with type 1 diabetes mellitus (T1DM) from a public health care system in developed areas of developing country, considerin...
Autores principales: | Hu, Sicui, Yang, Hongxiu, Chen, Zhihong, Leng, Xuefei, Li, Cheng, Qiao, Lingyan, Lv, Weiqing, Li, Tang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043415/ https://www.ncbi.nlm.nih.gov/pubmed/33859614 http://dx.doi.org/10.3389/fendo.2021.604028 |
Ejemplares similares
-
Postnatal growth of infants with neonatal diabetes: Insulin pump (CSII) versus Multiple Daily Injection (MDI) therapy
por: Alyafie, Fawzia, et al.
Publicado: (2019) -
HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
por: Scott, Emma S, et al.
Publicado: (2019) -
RT‐CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta‐analysis
por: William, Jimmy, et al.
Publicado: (2022) -
Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants
por: Mancioppi, Valentina, et al.
Publicado: (2023) -
CLIC MDI Overview
por: Gatignon, Lau
Publicado: (2012)